BeStock  
Stocks › Biotechnology › VKTX

Viking Therapeutics VKTX

US equityMarket cap rank #2398Biotechnology
$24.77 −$1.07 (-4.14%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.10 +1.33%
Open$25.62
Prev close$25.84
Day range$24.67 – $26.50
Volume3.65M
Market cap$3.16B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$187.11M-89.8% YoY
Net profit-$183.19M-101.8% YoY
Diluted EPS-$1.55-91.4% YoY
Free cash flow-$138.19M-47.0% YoY
Operating cash flow-$138.19M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-35.4MDec '24$-45.6MMar '25$-65.6MJun '25$-90.8MSep '25$-157.7MDec '25$-158.3MMar '26$-128.0MJun '26$-183.2MSep '26

Diluted EPS by quarter

-0.32Dec '24-0.41Mar '25-0.58Jun '25-0.81Sep '25-1.38Dec '25-1.37Mar '26-1.10Jun '26-1.55Sep '26

Free cash flow by quarter

$-31.2MDec '24$-52.3MMar '25$-47.1MJun '25$-94.0MSep '25$-85.3MDec '25$-114.0MMar '26$-125.2MJun '26$-138.2MSep '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-96.4%
Return on assets-73.1%
Return on invested capital-83.3%
Current ratio7.27
Liabilities / assets39.8%
Cash & investments$959.81M
Total debt$254.67M
Net cash (debt)$705.14M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $0.00 $0.00 $0.00 $0.00 $0.00
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $187.11M $132.60M $164.13M $393.34M $164.74M
Selling and Admin Expenses $20.31M $16.84M $13.98M $48.39M $11.28M
-General & Admin Expense $20.31M $16.84M $13.98M $48.39M $11.28M
Research & Development $166.80M $115.75M $150.15M $344.96M $153.46M
Operating Profit -$187.11M -$132.60M -$164.13M -$393.34M -$164.74M
Net Non-Operating Interest Income (Expense) $3.93M $4.55M $5.80M $33.65M $7.04M
Non-Operating Interest Income $4.01M $4.55M $5.80M $33.70M $7.04M
Non-Operating Interest Expense $88,000.00 – – – –
Pretax Profit -$183.19M -$128.02M -$158.33M -$359.64M -$157.66M
Net Profit -$183.19M -$128.02M -$158.33M -$359.64M -$157.66M
Profit from Continuing Operations -$183.19M -$128.02M -$158.33M -$359.64M -$157.66M
Net Income to Parent Company -$183.19M -$128.02M -$158.33M -$359.64M -$157.66M
Net Income to Common Stockholders -$183.19M -$128.02M -$158.33M -$359.64M -$157.66M
Basic EPS -$1.55 -$1.10 -$1.37 -$3.19 -$1.38
Diluted EPS -$1.55 -$1.10 -$1.37 -$3.19 -$1.38
Other Income (Expense) – $30,000.00 – $55,000.00 $41,000.00
Gain on Sale of Security – $30,000.00 – $55,000.00 $41,000.00
Total Other Finance Costs – – – $56,000.00 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $977.17M $521.90M $608.24M $715.73M $715.73M
Total Current Assets $973.00M $517.56M $608.21M $715.60M $715.60M
Cash and Cash Equivalents & Short-Term Investments $959.81M $501.66M $602.96M $705.74M $705.74M
-Cash and Cash Equivalents $677.61M $125.75M $118.12M $165.81M $165.81M
-Short Term Investments $282.20M $375.91M $484.85M $539.93M $539.93M
Prepaid Assets $10.01M $14.96M $4.02M $8.05M $8.05M
Other Current Assets $3.18M $941,000.00 $1.22M $1.81M $1.81M
Total Non-Current Assets $4.17M $4.33M $33,000.00 $131,000.00 $131,000.00
Net PPE $3.85M $4.01M $0.00 $85,000.00 $85,000.00
-Gross PPE $3.85M $4.01M $0.00 $85,000.00 $85,000.00
Non-Current Prepaid Assets $113,000.00 $113,000.00 $33,000.00 $46,000.00 $46,000.00
Other Non-Current Assets $202,000.00 $211,000.00 – – –
Total Liabilities $388.57M $113.58M $106.33M $76.67M $76.67M
Total Current Liabilities $133.90M $109.66M $106.33M $76.67M $76.67M
Payables $82.13M $69.01M $67.18M $53.25M $53.25M
-Accounts Payable $82.13M $69.01M $67.18M $53.25M $53.25M
Current Accrued Expenses $51.74M $40.48M $39.14M $23.28M $23.28M
Short-Term Debt and Capital Lease Obligation $24,000.00 $161,000.00 – $137,000.00 $137,000.00
-Current Capital Lease Obligation $24,000.00 $161,000.00 $0.00 $137,000.00 $137,000.00
Total Non-Current Liabilities $254.67M $3.93M $0.00 $0.00 $0.00
Long Term Debt and Capital Lease Obligation $254.67M $3.93M – $0.00 $0.00
-Long Term Debt $250.66M – – – –
-Long Term Capital Lease Obligation $4.01M $3.93M – $0.00 $0.00
Total Equity $588.60M $408.32M $501.92M $639.06M $639.06M
Stockholders' Equity $588.60M $408.32M $501.92M $639.06M $639.06M
Capital Stock $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00
-Common Stock $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.91B $1.54B $1.51B $1.49B $1.49B
Retained Earnings -$1.32B -$1.13B -$1.01B -$847.55M -$847.55M
Gains/Losses Not Affecting Retained Earnings -$1.70M -$1.15M -$856,000.00 $378,000.00 $378,000.00
Less: Treasury Stock – – $0.00 $0.00 $0.00
Non-Current Deferred Assets – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$138.19M -$125.17M -$113.98M -$278.69M -$85.29M
Net cash flow from continuing operations -$138.19M -$125.17M -$113.98M -$278.69M -$85.29M
Net Income from Continuing Operations -$183.19M -$128.02M -$158.33M -$359.64M -$157.66M
Gain/Loss from Continuing Operations $0.00 – – -$55,000.00 -$41,000.00
Depreciation & Depletion & Amortization $158,000.00 $157,000.00 $85,000.00 $431,000.00 $94,000.00
Other Non-Cash Items $91,000.00 $111,000.00 $1,000.00 $66,000.00 -$16,000.00
Change in Working Capital $27.65M -$7.64M $35.22M $48.98M $65.48M
-Change in Receivables $1.47M $120,000.00 $936,000.00 $5.08M $413,000.00
-Change in Prepaid Assets $2.71M -$10.74M $4.63M -$5.20M $14.28M
-Change in Payables and Accrued Expense $23.61M $3.17M $29.79M $49.61M $50.90M
-Change in Other Current Liabilities -$139,000.00 -$191,000.00 -$139,000.00 -$505,000.00 -$116,000.00
Net cash flow from investing $92.52M $109.43M $54.19M $341.39M $75.61M
Net Cash Flow from Continuing Investing Activities $92.52M $109.43M $54.19M $341.39M $75.61M
Net Investment Purchase and Sale $92.52M $109.43M $54.19M $341.39M $75.61M
Financing Cash Flow $597.55M $23.59M $12.08M $76.44M $75.10M
Net Cash Flow from Continuing Financing Activities $597.55M $23.59M $12.08M $76.44M $75.10M
Proceeds from Stock Option Exercised $753,000.00 $1.01M $450,000.00 $2.49M $1.16M
Net Other Financing Charges $48.52M – – $73.95M –
Ending Cash Balance $677.81M $125.96M $118.12M $165.81M $165.81M
Net Change in Cash $551.88M $7.85M -$47.71M $139.14M $65.43M
Beginning Cash Balance $125.96M $118.12M $165.81M $26.68M $100.38M
Effect of Exchange Rate Changes -$26,000.00 $0.00 $16,000.00 -$8,000.00 $9,000.00
Free Cash Flow -$138.19M -$125.17M -$113.98M -$278.69M -$85.29M
Net Common Stock Issuance – – $11.63M $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on VKTX.

Sign in to join the discussion.

Scroll to Top